{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:42:25Z","timestamp":1785411745633,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341230"],"award-info":[{"award-number":["82341230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240003"],"award-info":[{"award-number":["BK20240003"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.apsb.2025.02.011","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:10:21Z","timestamp":1739848221000},"page":"1991-2007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["SAE1 promotes tumor cell malignancy via SUMOylation and liquid\u2013liquid phase separation facilitated nuclear export of p27"],"prefix":"10.1016","volume":"15","author":[{"given":"Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7650-3059","authenticated-orcid":false,"given":"Jinjun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-5102","authenticated-orcid":false,"given":"Ye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.02.011_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.02.011_bib2","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.3390\/cancers12123764","article-title":"Ubiquitination and ubiquitin-like modifications in multiple myeloma: biology and therapy","volume":"12","author":"Wirth","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2025.02.011_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.ade3925","article-title":"Decrypting drug actions and protein modifications by dose- and time-resolved proteomics","volume":"380","author":"Zecha","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.02.011_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","article-title":"Sumoylation: a regulatory protein modification in health and disease","volume":"82","author":"Flotho","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2025.02.011_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","article-title":"Targeting SUMO signaling to wrestle cancer","volume":"7","author":"Kroonen","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apsb.2025.02.011_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-019-0392-9","article-title":"SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways","volume":"17","author":"Yang","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.apsb.2025.02.011_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/cells10010178","article-title":"SUMO-activating enzyme subunit 1 (SAE1) is a promising diagnostic cancer metabolism biomarker of hepatocellular carcinoma","volume":"10","author":"Ong","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2025.02.011_bib8","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood-2009-03-211045","article-title":"The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome","volume":"115","author":"Driscoll","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.02.011_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba7791","article-title":"A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models","volume":"13","author":"Lightcap","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2025.02.011_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2025.02.011_bib11","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","article-title":"United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia","volume":"19","author":"Soignet","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2025.02.011_bib12","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/sj.onc.1204762","article-title":"Arsenic trioxide, a therapeutic agent for APL","volume":"20","author":"Zhang","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2025.02.011_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301264","article-title":"GART functions as a novel methyltransferase in the RUVBL1\/\u03b2-catenin signaling pathway to promote tumor stemness in colorectal cancer","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2025.02.011_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-021-02220-1","article-title":"AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma","volume":"41","author":"Gu","year":"2022","journal-title":"J Exp Clin Canc Res"},{"key":"10.1016\/j.apsb.2025.02.011_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejim.2010.09.010","article-title":"Colchicine in clinical medicine. A guide for internists","volume":"21","author":"Cocco","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.apsb.2025.02.011_bib16","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1007\/s13277-016-4972-7","article-title":"Colchicine induces autophagy and senescence in lung cancer cells at clinically admissible concentration: potential use of colchicine in combination with autophagy inhibitor in cancer therapy","volume":"37","author":"Bhattacharya","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.apsb.2025.02.011_bib17","first-page":"607","article-title":"Clinical experience with Colcemid in true polycythemia and chronic myelogenic leukemia","volume":"8","author":"Jyo","year":"1961","journal-title":"Naika Hokan"},{"key":"10.1016\/j.apsb.2025.02.011_bib18","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood-2009-12-261032","article-title":"Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients","volume":"116","author":"Broyl","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.02.011_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nature08765","article-title":"Active site remodelling accompanies thioester bond formation in the SUMO E1","volume":"463","author":"Olsen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.02.011_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New method for fast and accurate binding-site identification and analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.apsb.2025.02.011_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2025.02.011_bib22","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.011_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41392-021-00746-6","article-title":"BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Tar"},{"key":"10.1016\/j.apsb.2025.02.011_bib24","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2009-08-237941","article-title":"IL-6 and MYC collaborate in plasma cell tumor formation in mice","volume":"115","author":"Rutsch","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.02.011_bib25","first-page":"22949","article-title":"In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.apsb.2025.02.011_bib26","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1158\/0008-5472.CAN-19-3663","article-title":"p27 as a transcriptional regulator: new roles in development and cancer","volume":"80","author":"Razavipour","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.02.011_bib27","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1038\/s41598-019-42450-0","article-title":"p27\/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma","volume":"9","author":"Currier","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.02.011_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0962-8924(02)00043-0","article-title":"New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?","volume":"13","author":"Coqueret","year":"2003","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2025.02.011_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","article-title":"The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy","volume":"8","author":"Chu","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.02.011_bib30","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.1516277113","article-title":"Cryptic sequence features within the disordered protein p27 regulate cell cycle signaling","volume":"113","author":"Das","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.02.011_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.03.002","article-title":"Atomic basis of CRM1-cargo recognition, release and inhibition","volume":"27","author":"Fung","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2025.02.011_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2025.02.011_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.apsb.2018.03.001","article-title":"The application of CAR-T cell therapy in hematological malignancies: advantages and challenges","volume":"8","author":"Zhao","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.011_bib34","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","article-title":"Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer","volume":"64","author":"Langston","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.011_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100758","article-title":"Selinexor, selective inhibitor of nuclear export: unselective bullet for blood cancers","volume":"46","author":"Benkova","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.apsb.2025.02.011_bib36","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.apsb.2024.03.013","article-title":"Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma","volume":"14","author":"Lu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.011_bib37","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1126\/science.1172046","article-title":"Germline P granules are liquid droplets that localize by controlled dissolution\/condensation","volume":"324","author":"Brangwynne","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.02.011_bib38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.canlet.2017.06.031","article-title":"p27 and human cancers: a reappraisal of a still enigmatic protein","volume":"403","author":"Bencivenga","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.02.011_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0033583511000060","article-title":"Expanding the proteome: disordered and alternatively folded proteins","volume":"44","author":"Dyson","year":"2011","journal-title":"Q Rev Biophys"},{"key":"10.1016\/j.apsb.2025.02.011_bib40","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1074\/jbc.R115.695056","article-title":"Modulation of intrinsically disordered protein function by post-translational modifications","volume":"291","author":"Bah","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.02.011_bib41","article-title":"The liquid nucleome\u2014phase transitions in the nucleus at a glance","volume":"132","author":"Strom","year":"2019","journal-title":"J Cel Sci"},{"key":"10.1016\/j.apsb.2025.02.011_bib42","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1126\/science.aaz4427","article-title":"Partitioning of cancer therapeutics in nuclear condensates","volume":"368","author":"Klein","year":"2020","journal-title":"Science"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525000656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525000656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:16:18Z","timestamp":1762604178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2211383525000656"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.02.011","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SAE1 promotes tumor cell malignancy via SUMOylation and liquid\u2013liquid phase separation facilitated nuclear export of p27","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}